Table 1.
Descriptive data and outcome of COVID-19
| Descriptive Statistics N = 335(%) | ||
|---|---|---|
| Age in years (mean ± SD) | 48.62 ± 12.07 | |
| Gender M(F) | 65 (270) | |
| Duration of AIRD in months | Less than 24 Months | 60 (17.91%) |
| Greater than or Equal to 24 Months | 275 (82.09%) | |
| Smoking History | 5 (1.49%) | |
| DM | 43 (12.84%) | |
| HTN | 71 (21.19%) | |
| Obesity BMI > 30 | 11 (3.28%) | |
| Asthma/ILD | 9 (2.69%) | |
| Diagnosis | RA | 246 (73.43%) |
| PsA | 29 (8.66%) | |
| SpA | 35 (10.45%) | |
| Others | 25 (7.46%) | |
|
COVID-19 Infected Patients (N = 36) | ||
| Hospitalization | 10 (27.78%) | |
| O2 therapy | 7 (19.44%) | |
| ICU admission | 3 (8.33%) | |
| Mortality (Death) | 3 (8.33%) | |
AIRD: Autoimmune Rheumatic Diseases; DM: Diabetes Mellitus, HTN: Hypertension, BMI- Body Mass Index, ILD: Interstitial lung disease, RA: Rheumatoid Arthritis; PsA: Psoriatic Arthritis; SpA- Spondyloarthritis; ICU: Intensive care unit